Page last updated: 2024-10-25

cimetidine and Sjogren's Syndrome

cimetidine has been researched along with Sjogren's Syndrome in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomasko, MA1
Luskin, AT1

Other Studies

1 other study available for cimetidine and Sjogren's Syndrome

ArticleYear
Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
    The American journal of medicine, 1988, Volume: 85, Issue:2

    Topics: Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Middle Aged; Parotitis; Ranitidine

1988